XML 41 R24.htm IDEA: XBRL DOCUMENT

SUBSEQUENT EVENT	6 Months Ended
SUBSEQUENT EVENT	Mar. 31, 2017
Subsequent Events [Abstract]
SUBSEQUENT EVENT	On April 14, 2017, Ashland entered into a definitive agreement to acquire privately owned Pharmachem Laboratories, Inc., a leading provider of quality ingredients to the global health and wellness industries and high-value differentiated products to fragrance and flavor houses. Under terms of the stock purchase agreement, Ashland will pay $660 million in an all-cash transaction that is expected to be completed before the end of the June 2017 quarter. The acquisition, which is subject to customary closing conditions and required regulatory approvals, will be funded with bank financing and available cash.